STOCK OPTIONS AND WARRANTS (Details 3) - $ / shares |
12 Months Ended | |
---|---|---|
Dec. 31, 2023 |
Sep. 30, 2023 |
|
Exercisable, Number of Options | 889,151 | 887,901 |
Warrants Exercisable [Member] | ||
Weighted average remaining life in years | 2 years 7 months 6 days | |
Exercisable, Number of Options | 1,565,856 | |
Exercise price | $ 3.31 | |
Warrants Outstanding [Member] | ||
Weighted average remaining life in years | 2 years 7 months 6 days | |
Number of outstanding | 1,565,856 | |
3.31 [Member] | Warrants Exercisable [Member] | ||
Weighted average remaining life in years | 2 years 7 months 6 days | |
Exercisable, Number of Options | 1,565,856 | |
Exercise price | $ 3.31 | |
3.31 [Member] | Warrants Outstanding [Member] | ||
Weighted average remaining life in years | 2 years 7 months 6 days | |
Exercise price | $ 3.31 | |
Number of outstanding | 1,565,856 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|